Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy
Conditions: Hypotension; Heart Failure Interventions: Drug: Dapagliflozin; Drug: Sacubitril-Valsartan; Drug: Beta blocker; Drug: Mineralocorticoid Receptor Antagonist; Device: Cardiac resynchronization therapy and/or implantable cardioverter defibrillator Sponsor: Cheng-Hsin General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiac Resynchronization Therapy | Cardiology | Dapagliflozin | Diovan | Forxiga | Heart | Heart Failure | Hospitals | Research